GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...

Philadelphia-based Jefferson Health and Thomas Jefferson University filed a federal lawsuit Dec. 30 alleging that three insulin manufacturers and the nation’s largest pharmacy benefit managers ...

Filed under Oregon’s consumer protection law, the suit accuses drugmakers and pharmacy benefit managers of conspiring to ...

Oregon Attorney General Dan Rayfield filed a $900 million lawsuit against the nation's largest insulin manufacturers, ...

The lawsuit alleges three manufacturers coordinated with three pharmacy benefit managers in a scheme to inflate insulin ...

The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

For many women over 40, stubborn weight gain isn’t about willpower or calories — it’s about how changing hormones reshape ...

Drugmaker Cipla has launched Afrezza (insulin human) inhalation powder, the company said, about a year after the product got regulatory approval in India. The company has the exclusive distribution ...

The U-500 insulin delivery syringe. [Image from Embecta/BD] Embecta (Nasdaq:EMBC) today announced an expansion of its partnership with Direct Relief to mark World Diabetes Day. Today, Nov. 14, is ...

1 Department of Endocrinology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China 2 Department of Outpatient, The Central Hospital of Enshi Tujia and Miao ...